Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Home/Banking & Finance/Bandhan Bank Share Price Analysis April 2026
Banking & Finance

Bandhan Bank Share Price Analysis April 2026

By Zumedha Research Team on April 21, 2026 10 Min Read
Bandhan Bank — Zumedha Equity Research
Zumedha Equity Research
Research  ·  Analysis  ·  Insights
Current Market Price ACCUMULATE ₹176.10 as on 21 Apr 2026
Bandhan Bank Limited
Universal Commercial Bank · Microfinance Heritage · Financial Inclusion Leader · BSE: 541153 · NSE: BANDHANBNK
NSE BANDHANBNK
BSE 541153
ISIN INE545U01014
Face Value ₹10
52W H / L ₹192.48 / ₹134.25
Mkt Cap ₹28,261 Cr
Shares O/S ~160.5 Cr
Promoter 39.74%
Index S&P BSE 500
NII (FY25) ₹11,491 Cr +11.4% YoY
PAT (FY25) ₹2,745 Cr +23.1% YoY
GNPA (FY25) 4.71% Q3 FY26: 3.33%
NIM (Q3 FY26) 5.90% FY25: 7.1%
RoA (FY25) 1.5% Q4 FY25: 0.7%
CRAR (Q1 FY26) 19.4% Well capitalised
01 Business Overview

Bandhan Bank traces its origins to a 2001 NGO dedicated to women’s empowerment and rural financial inclusion in West Bengal. Becoming India’s largest NBFC-MFI by 2010, it obtained an RBI universal banking licence in 2014 and commenced banking operations in August 2015 — the first microfinance institution ever to do so. The bank’s IPO in March 2018, subscribed 15 times, raised capital for pan-India expansion and underlined institutional confidence in the franchise.

Headquartered in Kolkata, Bandhan Bank today operates through four reportable segments: Treasury, Retail Banking, Corporate/Wholesale Banking, and Other Banking Business. Its pan-India network spans over 6,350 banking outlets across 35 states and union territories, serving 3.14 crore customers with more than 73,000 employees. Total business crossed the ₹3 lakh crore milestone in Q3 FY26, with deposits of ₹1.57 lakh crore and gross advances of ₹1.45 lakh crore.

Bandhan 2.0 Strategic Pivot: The bank is undergoing a deliberate transformation from a microfinance-concentrated institution toward a diversified universal bank. Under MD & CEO Partha Pratim Sengupta, the Bandhan 2.0 programme has driven secured lending to exceed 57% of the loan book as of Q3 FY26 — up from barely 30% three years ago. The non-EEB (Emerging Entrepreneurs Business) book grew 29% YoY in Q4 FY25, with housing, retail, and wholesale banking emerging as growth engines alongside the legacy microfinance vertical.

The bank’s Emerging Entrepreneurs Business (EEB) — microfinance group loans to rural female borrowers — remains the largest single segment but is declining as a share of the total. The EEB portfolio is the primary source of credit stress in FY25–26, as the broader MFI industry faces a severe over-leveraging cycle driven by multiple lender exposure. Bandhan’s collection efficiency for EEB loans has, however, recovered to 98.2% in Q3 FY26, signalling stabilisation.

02 Historical Financials
Metric (₹ Crore)FY21FY22FY23FY24FY25Q3 FY26
Net Interest Income7,3847,6269,12810,31611,4912,689
Profit After Tax2,2051,9022,1952,2292,745206
Gross Advances81,98098,6031,09,1221,23,9751,37,0001,45,000
Total Deposits77,97296,3311,08,0691,35,0001,51,0001,57,000
GNPA Ratio (%)6.86.54.93.84.73.33
NNPA Ratio (%)3.51.71.21.11.31.0
NIM (%)8.07.37.17.47.15.9
RoA (%)2.21.61.81.81.5~0.7*
RoE (%)16.212.814.013.011.6~5.2*
CASA Ratio (%)43.042.036.533.330.527.0
PCR (Incl. Write-offs)—75.576.884.586.584.3

* Q4 FY25 annualised. Note: FY21–FY24 advances/deposits are approximate; Q3 FY26 figures are unaudited quarterly data.

The FY25 full-year PAT of ₹2,745 crore represents a 23% YoY recovery, though this masks a deteriorating intra-year trajectory: PAT for Q3 FY25 fell 42% YoY as provisions surged against the MFI stress. The 9M FY26 PAT of ₹689 crore represents a 72% YoY decline, with Q3 FY26 at ₹206 crore (−52% YoY), reflecting peak provisioning. However, the sequential trajectory — PAT up 84% QoQ in Q3 FY26 — is the more meaningful signal: the earnings trough appears to be behind the bank.

NIM compression from 7.4% in FY24 to 5.9% in Q3 FY26 is structural, driven by the EEB portfolio’s de-risking (lower yields on secured loans), higher cost of funds as CASA eroded, and the shift to term deposits. CASA ratio dropped from 43% in FY21 to 27% in Q3 FY26 — a key liability-side vulnerability that management is actively addressing via retail deposit mobilisation and digital banking channels.

03 DCF Valuation
Discounted Cash Flow — 10-Year Normalised Earnings Model
12.0% Risk-free 7.0% + Beta 1.25
5.0% Long-run GDP + Inclusion premium
₹1,100 Cr Recovery year; depressed earnings
₹2,800 Cr MOFSL estimates; RoA ~1.7%
DCF INTRINSIC VALUE (PER SHARE)
₹210–₹230
Upside: ~19–31% from CMP
DCF assumes PAT recovery to ₹2,800 Cr by FY27E and ₹4,200 Cr by FY30E as secured lending mix improves, credit costs normalise to sub-2%, and RoE recovers toward 15%+. At 1.2x FY27E P/BV, intrinsic value is ₹205–215. The model assigns a terminal multiple of 1.8x P/BV on FY36E book, discounted at 12% WACC. Given deep earnings trough in FY26, a price-to-book anchor (0.9–1.2x) supplements DCF.
YearFY26EFY27EFY28EFY29EFY30ETerminal
PAT (₹ Cr)1,1002,8003,4003,9004,200—
Growth YoY−60%+155%+21%+15%+8%5%
Discount Factor (12%)0.8930.7970.7120.6360.567—
PV of Earnings (₹ Cr)9822,2322,4212,4802,381~17,500
RoA Est.~0.5%~1.7%~1.9%~2.0%~2.1%Steady State
04 Buy Range — Entry Zones
◆ Strong Buy Below ₹140 Deep value entry; <0.8x FY27E P/BV. Meaningful margin of safety if MFI stress persists. Load aggressively for 2–3 year horizon.
◆ Accumulate ₹140 – ₹185 Current zone (CMP ₹176). 0.9–1.1x FY27E P/BV. Turnaround in progress; accumulate in tranches with a 24-month view. Risk-reward favourable.
◆ Fair Value ₹185 – ₹220 1.1–1.3x FY27E P/BV. Approaching DCF fair value range. Buy only on confirmed NPA improvement and promoter stake resolution clarity.

Zumedha View: At CMP ₹176, Bandhan Bank trades at ~1.1x FY27E P/BV and approximately 10x FY25 P/E — attractive relative to its normalised earnings power. The stock is in the Accumulate zone. Investors with a 24–36 month horizon and tolerance for near-term earnings volatility should build positions in tranches, with additional purchases on any dips below ₹155.

05 Buy Scenario Analysis
Bear Case ₹120–₹130 MFI stress accelerates; GNPA rises above 6%; promoter stake sale via OFS at steep discount; NIM stays compressed below 6.5% into FY27. PAT stays depressed at ₹800–1,000 Cr. P/BV drifts to 0.7x on weak return ratios.
Base Case ₹200–₹225 MFI stress peaks in FY26; GNPA normalises to ~3.5% by FY27; secured mix at 60%+; PAT recovers to ₹2,500–2,800 Cr by FY27; RoE at 13–14%; NIM stabilises at 7.0–7.2%. P/BV expands to 1.2x.
Bull Case ₹280–₹320 Faster-than-expected NPA resolution; promoter stake overhang resolved cleanly; RBI rate cuts boost NIM; secured book grows 25%+ CAGR; PAT approaches ₹4,000+ Cr by FY28; RoE at 15–17%. P/BV re-rates to 1.6–1.8x.

The base case is underpinned by Q3 FY26 data: GNPA already improved sharply from 5.0% to 3.33% in a single quarter following Bandhan’s ₹6,900 crore loan sell-off to ARCs. Collection efficiency at 98.2% and secured advances at 57% of the book validate the Bandhan 2.0 trajectory. SBI Mutual Fund’s RBI-approved 9.99% stake acquisition is a further institutional confidence signal.

06 Sell Range — Exit Zones
◆ Reduce ₹220 – ₹260 Book partial profits. Approaching full DCF value. Reduce to core holding (30–40% of position). Reassess after Q4 FY26 results.
◆ Exit Trigger ₹260 – ₹310 1.5–1.7x FY27E P/BV. Significant premium to fair value unless FY28E earnings justify. Exit unless secular re-rating thesis remains intact with clear execution milestones.
◆ Avoid / Overvalued Above ₹310 2.0x+ P/BV. Fully priced in on bull case. Do not add. Strong sell on any reversal signal: GNPA re-deterioration, management change, or RBI adverse action.
07 Sell Scenario Analysis
Overvalued ₹220–₹260 Stock priced ahead of fundamentals. Partial profit booking warranted. Credit cost still elevated, NIM recovery unconfirmed. Trade, don’t hold at this level.
Exit Trigger ₹260–₹310 Full exit unless Q4 FY26 + Q1 FY27 results show RoE trending toward 15%+ and GNPA sub-3%. Promoter stake resolution is a must-have at these levels.
Structural Break Below ₹130 (if owned) Stop-loss for traders. Investors: cut position if consecutive quarter GNPA rises, RoA stays below 0.5% into FY27, or promoter OFS executed at heavy discount.
08 Future Growth & Earnings Outlook

Loan Book Diversification (Bandhan 2.0): The most significant structural change underway is the deliberate shift away from EEB. The non-micro credit book grew 29% YoY in Q4 FY25, with retail (non-housing) up 57% YoY and wholesale banking up 32% YoY in Q3 FY26. Secured advances now constitute 57% of the loan book, up from roughly 30–35% three years prior. Management targets 60–65% secured mix by FY27, which will fundamentally reduce earnings volatility.

Digital Banking & CBS: The newly launched Core Banking System (CBS) is expected to underpin digital capability improvements — mobile banking penetration, automated lending underwriting, and doorstep banking scale. Digital initiatives have been flagged as Q4 FY26 and FY27 priority. Fee income from cross-selling (mutual funds, insurance, merchant payments) offers margin augmentation upside.

NIM Recovery Path: NIM declined from 7.4% in FY24 to 5.9% in Q3 FY26, the most severe compression in Bandhan’s post-listing history. Recovery depends on: (a) EEB portfolio stabilisation and repricing, (b) secured book yield improvement as unsecured legacy stress is written off, and (c) CASA ratio recovery as digital channels mature. MOFSL estimates NIM stabilising at 6.5–7.0% by FY27E.

Credit Cost Normalisation: Credit cost surged to 2.9% in FY25 (3.4% on 9M basis). MOFSL projects normalisation to 2.2% in FY26E and 1.8% in FY27E. The aggressive ARC sell-off of ₹6,900 crore in written-off EEB loans in Q3 FY26 has cleaned the balance sheet, and the SMA book declined 50 basis points QoQ to 3.3% — a lead indicator of improving stress.

MetricFY25 (Actual)FY26EFY27EFY28E
NII (₹ Cr)11,49110,80012,50014,800
PAT (₹ Cr)2,7451,1002,8003,800
NIM (%)7.16.36.87.0
Credit Cost (%)2.92.21.81.4
GNPA (%)4.714.03.52.8
RoA (%)1.50.51.72.0
RoE (%)11.64.014.316.5

FY26E–FY28E are Zumedha estimates informed by MOFSL, CLSA, and management guidance. Estimates subject to MFI sector macro and promoter stake resolution outcomes.

09 Risks & Catalysts
◆ Catalysts (Upside Triggers)
Faster-than-expected MFI stress resolution — Q4 FY26 results (due 28 April 2026) could confirm GNPA below 3.0%, triggering a valuation re-rating
Promoter stake overhang resolution — a clean, well-priced reduction of Bandhan Financial Services’ stake to below 26% is the single biggest re-rating catalyst; IPO of holding company or strategic PE sale would remove the supply overhang permanently
RBI rate cut cycle — rate reductions improve borrower repayment capacity in MFI segment and compress cost of funds, aiding NIM recovery
SBI Mutual Fund 9.99% stake acquisition (RBI approved, Feb 2026) — validates institutional confidence; further DII accumulation expected
Digital banking traction — CBS-led mobile banking growth and fee income diversification could surprise on NIR upside
CLSA high-conviction Outperform with ₹220 target; Motilal Oswal Buy at ₹175; Emkay Buy at ₹180 — consensus turning positive
◆ Risks (Downside Factors)
Promoter stake sale executed at a steep discount via bulk deal / OFS — significant supply shock risk; Bandhan Financial Services holds 39.74%, ~13.74% above RBI’s 26% cap, with a self-imposed June 2026 deadline
MFI sector second-wave stress — micro-credit industry remains vulnerable to over-leverage, political interference (loan waivers), and adverse monsoon outcomes in Eastern India
Geographic concentration — ~70% of branches are in East and Northeast India; Assam, West Bengal, and Odisha elections or state-level political events can disrupt collections
CASA erosion continuation — CASA at 27% in Q3 FY26 (vs. 43% in FY21); further decline raises cost of funds and structurally compresses NIM, weighing on long-run RoE
Management succession uncertainty — new MD & CEO Partha Pratim Sengupta (since 2023) still building credibility; Bandhan 2.0 execution must deliver visible results by FY27
Regulatory risk — RBI has previously imposed restrictions on Bandhan for promoter holding breaches; any adverse regulatory action in lending or promoter compliance could be materially negative
10 Peer Comparison
BankMkt Cap (₹ Cr)P/E (TTM)P/BVNIM (%)GNPA (%)RoA (%)RoE (%)Rating
Bandhan Bank28,261~26x (dep.)1.1x5.93.33~0.7~5.2Accumulate
HDFC Bank13,70,00019x2.7x3.61.41.916.5Accumulate
ICICI Bank9,60,00018x3.2x4.52.22.418.0Buy
YES Bank58,000~40x1.0x2.52.00.65.5Accumulate
RBL Bank18,00026x1.2x5.02.91.010.2Neutral
Ujjivan SFB7,8008x1.1x8.82.32.520.0Watch
Sector Median—18–22x1.5–2.0x4.0–5.02.0–3.01.5–2.013–16—

Relative to peers, Bandhan Bank is in a recovery phase — its GNPA of 3.33% remains elevated vs. ICICI Bank and HDFC Bank but has improved sharply from Q2 FY26’s 5.0%. Its NIM of 5.9% is one of the highest in the sector (even after compression), and its CRAR of 19.4% provides a substantial capital buffer. The 1.1x P/BV looks undemanding for a bank with demonstrated 15%+ RoE capability when the book is normalised. The discount to intrinsic value is primarily a function of near-term earnings depression and the structural promoter overhang — both of which are transient rather than permanent impairments.

★ Verdict
ACCUM-
ULATE
BANDHAN BANK ₹176.10 · 21 Apr 2026
Target: ₹210–₹230 24–36 month horizon
A Turnaround at Discount — But Patience Is the Price

Bandhan Bank is one of India’s most asymmetric risk-reward opportunities in private banking today — for patient investors who understand what they own. The bank is not broken; it is in transition. The Bandhan 2.0 strategy is structurally sound: replacing volatile unsecured microfinance with a diversified secured loan book is precisely the right medicine, and the early numbers — 57% secured mix, 27% YoY secured growth, collection efficiency at 98.2% — validate execution.


The near-term earnings are severely depressed (FY26E PAT ~₹1,100 Cr vs. FY25’s ₹2,745 Cr), and two overhangs persist: the promoter stake dilution deadline and the MFI stress tail. However, at 1.1x FY27E P/BV and with Q3 FY26 showing the sharpest sequential GNPA improvement in years (5.0% → 3.33% in one quarter), the balance of risks is tilting favourably. We rate Bandhan Bank as ACCUMULATE at CMP ₹176, with a 24–36 month target of ₹210–₹230 in the base case, and emphasise buying in tranches with additional allocation on any weakness toward ₹150–155. Q4 FY26 results on 28 April 2026 are the next key catalyst.

Disclaimer: This report has been prepared by Zumedha Equity Research for informational and educational purposes only. It does not constitute investment advice, a solicitation, or an offer to buy or sell any securities. The views expressed are based on publicly available information and management disclosures as of April 2026. Zumedha Equity Research and its associates may or may not hold positions in the securities discussed. Equity investments are subject to market risk; past performance is not indicative of future returns. Readers are advised to consult their SEBI-registered financial advisor before making any investment decision. Data sourced from company filings, exchange disclosures, Motilal Oswal Securities, CLSA, Emkay Global, and Tickertape/Screener. All financial projections are estimates and may differ materially from actual outcomes.
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Havells DCF Valuation Share Pprice Analysis April 2026

Next

ICICI Prudential Large Cap Fund Analysis April 2026

Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS